PHS
TSBX

PFM Health Sciences’s Turnstone Biologics TSBX Stock Holding History

PFM Health Sciences’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-932,348
Closed -$382K – 74
2025
Q1 		$382K Hold
932,348
– – 0.03% 65
2024
Q4 		$463K Hold
932,348
– – 0.03% 83
2024
Q3 		$519K Hold
932,348
– – 0.03% 75
2024
Q2 		$2.44M Buy
932,348
+11,372
+1% +$32.5K 0.12% 66
2024
Q1 		$2.41M Buy
920,976
+287,663
+45% +$823K 0.11% 80
2023
Q4 		$1.61M Sell
633,313
-891,397
-58% -$2.33M 0.1% 62
2023
Q3 		$6.01M Buy
+1,524,710
New +$13.6M 0.28% 60

Other funds holding TSBX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFM Health Sciences's TSBX Position: Q2 2025 in Review

PFM Health Sciences sold out of Turnstone Biologics (TSBX) in Q2 2025, closing a stake of 932,348 shares — an estimated $382K sold.

PFM Health Sciences first reported a position in TSBX in Q3 2023 and held it in 7 quarters. The position peaked at $6.01M in Q3 2023. 23 funds tracked by Wall St. Rank hold TSBX as of Q2 2025.

  • PFM Health Sciences reported no remaining Turnstone Biologics position as of Q2 2025 after selling out during the quarter.
  • PFM Health Sciences sold 932,348 Turnstone Biologics shares in Q2 2025, an estimated $382K.
  • PFM Health Sciences first reported a position in Turnstone Biologics in Q3 2023 and held it in 7 quarters.
  • PFM Health Sciences's Turnstone Biologics position peaked at $6.01M in Q3 2023.
  • 23 funds tracked by Wall St. Rank held Turnstone Biologics as of Q2 2025.

Based on PFM Health Sciences's 13F filing for Q2 2025, filed 14 Aug 2025.